# Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction

> **NCT05242107** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 70 (actual)

## Conditions studied

- Lipid Profile
- Neonates
- Intrauterine Growth Restriction

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 supplement group
- **OTHER:** Full feeding without receiving any supplementation group

## Key facts

- **NCT ID:** NCT05242107
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05242107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05242107, "Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05242107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*